Ellogon
Healthtech · Amsterdam, NL
AI for patient selection in cancer immunotherapy.
Funding history
| Date | Round | Amount |
|---|
| Mar 2024 | Funding round Ellogon, an Amsterdam cancer-immunotherapy AI startup, raised EUR1M from ROM InWest and UvA Ventures Holding. | $1.1M |
Investors
ROM InWestUvA Ventures Holding
Similar companies in Healthtech
Explore funding flow on EquityFlow →